Bone mineral density and bone turnover in asthmatics treated with long- term inhaled or oral glucocorticoids

Journal of Bone and Mineral Research

Volumn 13, Issue 8, 1998, Pages 1283-1289

  Ebeling, Peter R ^a,b   Erbas, Bircan ^b   Hopper, John L ^b   Wark, John D ^a,b   Rubinfeld, A Roman ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; OSTEOPOROSIS; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ASTHMA; BECLOMETHASONE; BIOLOGICAL MARKERS; BONE DENSITY; BUDESONIDE; DEHYDROEPIANDROSTERONE SULFATE; DENSITOMETRY, X-RAY; FEMALE; FEMUR; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; RIBS;

EID: 0031825521     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.8.1283     Document Type: Article

References (28)

1. Barnes PJ 1995 Inhaled glucocorticoids for asthma. N Engl J Med 332:868-875.
2. Hanania NA, Chapman KR, Kesten S 1995 Adverse effects of inhaled corticosteroids. Am J Med 98:196-208.
3. Toogood JH, Jennings B, Hodsman AB, Baskerville J, Fraher LJ 1991 Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 88:572-580.
4. Pouw EM, Prummel MF, Oosting H, Roos CM, Endert E 1991 Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ 302:627-628.
5. Puolijoki H, Lippo K, Herrala J, Herrala J, Salmi J, Tala E 1992 Inhaled beclomethasone decreases serum osteocalcin in postmenopausal osteoporotic women. Bone 13:285-288.
6. Leech JA, Hodder RV, Ooi DS, Gay J 1993 Effects of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women. Am Rev Respir Dis 148:113-115.
7. Jennings BH, Andersson KE, Johansson SA 1991 Assessment of systemic effects of inhaled glucocorticoids: Comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 40:77-82.
8. Ali NJ, Capewell S, Ward MJ 1991 Bone turnover during high dose inhaled corticosteroid treatment. Thorax 46:160-164.
9. Packe GE, Douglas JG, McDonald AF, Robins SP, Reid DM 1992 Bone density in asthmatic patients taking high dose inhaled beclomethasone and intermittent systemic corticosteroids. Thorax 47:414-417.
10. Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G 1986 Corticosteroids and bone mass in asthma: Comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J 293:1463-1466.
11. Wolff AH, Adelsberg B, Aloia J, Zitt M 1991 Effect of inhaled corticosteroid on bone density in asthmatic patients: A pilot study. Ann Allergy 67:117-121.
12. Boulet LP, Giguere MC, Milot J, Brown J 1994 Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol 94:796-803.
13. Ip M, Lam K, Yam L, Kung A, Ng M 1994 Decreased bone density in premenopausal asthma patients receiving long term inhaled steroids. Chest 105:1722-1727.
14. Eyre DR, Koob TJ, Van Ness KP 1984 Quantitation of hydroxypyridinium crosslinks of collagen in urine using ionpaired reversed-phase high-performance liquid chromatography. Anal Biochem 137:380-388.
15. Colwell A, Russell RGG, Eastell R 1993 Factors affecting the assay of urinary 3-hydroxypyridinium cross-links of collagen as markers of bone resorption. Eur J Clin Invest 23:341-349.
16. Duda RJ Jr., O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL 1988 Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: Effects of age, sex and metabolic bone disease. J Clin Endocrinol Metab 66:951-957.
17. McCullagh P, Nelder JA 1989 Generalized linear models. In: Monographs on Statistics and Applied Probability, 2nd Ed, Vol 37. Chapman and Hall, London, U.K.
18. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, Wark JD 1996 Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 81:3366-3371.
19. Sambrook P, Birmingham J, Kempler S, Kelly P, Eberl S, Pocock N, Yeates M, Eisman J 1990 Corticosteroid effects on proximal femur bone loss. J Bone Miner Res 5:1211-1216.
20. Hanania NA, Chapman KR, Sturtridge WC, Sturtridge WC, Szalai JP, Kesten S 1995 Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 96:571-579.
21. Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Eduard C, Darby AJ 1979 Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1:303-319.
22. Dempster DW 1989 Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 4:137-141.
23. Toogood JH, Baskerville JC, Markov AE, Hodsman AB, Fraher LJ, Jennings B, Haddad RG, Drost D 1995 Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol 94:157-166.
24. Smith BJ, Buxton JR, Dickeson J, Heller RF 1994 Does beclomethasone dipropionate suppress deydroepiandosterone sulphate in postmenopausal women? Aust N Z J Med 24:396-400.
25. Prummel MF, Wieringa WM, Lips P, Sanders GT, Sauerwein HP 1991 The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 72:382-386.
26. Toogood JH, Crilly RG, Jones G, Nadeau J, Wells GA 1988 Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis 138:57-61.
27. Clarke BL, Ebeling PR, Jones JD, Riggs BL, Fitzpatrick LA 1992 Increased bone turnover with aging in men is not due to testosterone deficiency. Proceedings of the 74th Annual Meeting of the Endocrine Society, abstract A1071.
28. Ebeling P, Kiovisto VA 1994 Physiological importance of deydroepiandosterone. Lancet 343:1479-1481.